Trial Profile
Minimum Effective Dose of Intrathecal Ropivacaine Required for Cesarean Delivery: A Prospective, Randomized Comparison Between L2-3 and L3-4 Approach
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Mar 2018
Price :
$35
*
At a glance
- Drugs Ropivacaine (Primary)
- Indications Anaesthesia
- Focus Therapeutic Use
- 24 Apr 2017 Status changed from recruiting to completed.
- 07 Oct 2015 New trial record